The effects of monoclonal anti‐CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia
Transfusion2019Vol. 59(7), pp. 2248–2254
Citations Over TimeTop 10% of 2019 papers
Charlotte Brierley, Julie Staves, Corran Roberts, Hannah Johnson, Paresh Vyas, Lawrence T. Goodnough, M. F. Murphy
Abstract
Treatment with Hu5F9-G4 in patients with AML resulted in an Hb decline and increased transfusion requirements. Problems with ABO blood typing and compatibility testing were widely observed and should be expected by centers treating recipients of Hu5F9-G4.
Related Papers
- Reference Intervals of Reticulocyte Parameters using ADVIA 120(2003)
- [New reticulocyte indices and their utility in hematologic diagnosis].(2000)
- The Applying of Reticulocyte and Its Parameters in an Anemia(2005)
- Application of reticulocyte parameters in children's blood diseases(2006)
- → Reticulocyte Indices(2022)